Skip to main content
OpenTrials

Clinical trial condition

Epileptic Syndromes

Explore clinical trials studying Epileptic Syndromes. Study availability and eligibility vary by location and protocol.

209 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Epileptic Syndromes trial results

Active, not recruiting

RNS System LGS Feasibility Study

NCT05339126

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)

NCT06719141

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Austin Hospital Heidelberg, Victoria, Australia
  • Instituto de Neurologia de Curitiba (INC) Curitiba, Paraná, Brazil
  • Hôpital Roger Salengro Lille, Nord, France
  • AP-HP - Hôpital universitaire Robert-Debré Paris, France
View all 116 locations
View Trial Details
Active, not recruiting

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT06315322

Conditions
Brain Diseases, Central Nervous System Diseases, Childhood Absence Epilepsy, +6 more
Locations
  • Ep0224 50140 Birmingham, Alabama, United States
  • Ep0224 50638 New Brunswick, New Jersey, United States
  • Ep0224 50640 Winston-Salem, North Carolina, United States
  • Ep0224 20321 Tbilisi, Georgia
View Trial Details
Active, not recruiting

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

NCT05044819

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +27 more
Locations
  • Clinical Trial Site Little Rock, Arkansas, United States
  • Clinical Trial Site Downey, California, United States
  • Clinical Trial Site Long Beach, California, United States
  • Clinical Trial Site Sacramento, California, United States
View all 26 locations
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

NCT05485831

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +25 more
Locations
  • Policlinico Sant'Orsola di Bologna Bologna, Italy
  • NPI AOU Mater Domini Università Magna Graecia Catanzaro, Italy
  • Università degli studi "G. D'annunzio" Chieti Chieti, Italy
  • Azienda Ospedaliera Universitaria Meyer Neurologia Pediatrica Florence, Italy
View all 18 locations
View Trial Details
Active, not recruiting

A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.

NCT05064878

Conditions
Brain Diseases, CDKL5 Deficiency Disorder, CDKL5 deficiency disorder, +14 more
Locations
  • Ep0216 154 Birmingham, Alabama, United States
  • Ep0216 144 Los Angeles, California, United States
  • Ep0216 101 San Francisco, California, United States
  • Ep0216 173 Aurora, Colorado, United States
View all 46 locations
View Trial Details

Related conditions